Brown-Séquard Syndrome

Comprehensive Clinical Guide: Brown-Séquard Syndrome (BSS)

Brown-Séquard Syndrome (BSS), or hemicord syndrome, represents a rare but clinically distinct form of spinal cord injury (SCI). It is characterized by a lesion involving a lateral hemisection of the spinal cord, resulting in a unique pattern of ipsilateral motor and proprioceptive loss paired with contralateral pain and temperature sensation deficit. This guide provides an exhaustive clinical overview for medical professionals, clinicians, and specialists.

1. Introduction & Overview

Brown-Séquard Syndrome is named after the French physiologist Charles-Édouard Brown-Séquard, who first described the clinical phenomenon in 1849 after observing it in animals and subsequently in human patients. Unlike complete spinal cord injuries, BSS presents as an incomplete injury, which often correlates with a more favorable prognosis for functional recovery.

The Clinical Triad

The core diagnostic hallmark of BSS is the dissociation of sensory and motor loss:
1. Ipsilateral (same side) motor paralysis: Corticospinal tract involvement.
2. Ipsilateral loss of proprioception, vibration, and fine touch: Dorsal column involvement.
3. Contralateral (opposite side) loss of pain and temperature sensation: Spinothalamic tract involvement.

2. Technical Specifications & Pathophysiology

To understand BSS, one must understand the anatomical "crossing over" (decussation) of the spinal tracts.

Anatomical Mechanisms

• Corticospinal Tract (CST): These motor fibers decussate at the level of the medullary pyramids. Therefore, a lesion in the spinal cord below the medulla affects the ipsilateral side.
• Dorsal Column-Medial Lemniscus Pathway (DCML): These fibers carry vibration, proprioception, and fine touch. They ascend ipsilaterally and do not decussate until they reach the medulla. A lesion here causes ipsilateral loss.
• Spinothalamic Tract (STT): These fibers carry pain and temperature. They decussate at the level of the spinal cord (usually 1–2 segments above the entry point). Consequently, a lesion in the spinal cord interrupts fibers that have already crossed from the opposite side, leading to contralateral loss.

Etiology

The etiology of BSS can be categorized into traumatic and non-traumatic causes:

3. Clinical Staging & Presentation

Patients with BSS rarely present with a "pure" hemisection. Most cases are "BSS-plus" syndromes, where the lesion is incomplete, and some degree of bilateral involvement is observed.

Clinical Staging Table

Standard Presentation Indicators

• Motor: Ipsilateral weakness or paralysis (hemiparesis/hemiplegia).
• Sensory: Ipsilateral loss of position/vibration sense (dorsal column); Contralateral loss of pain/temperature (spinothalamic).
• Autonomic: Potential for unilateral Horner’s Syndrome (if the lesion is above T1) and bowel/bladder dysfunction (though often transient in incomplete injuries).

4. Differential Diagnosis

Distinguishing BSS from other spinal pathologies is critical for surgical and medical management:

1. Syringomyelia: Usually causes bilateral "cape-like" loss of pain and temperature sensation.
2. Anterior Cord Syndrome: Characterized by bilateral loss of motor function and pain/temperature, with preserved proprioception.
3. Central Cord Syndrome: Typically presents with "man-in-a-barrel" syndrome (weakness more pronounced in upper extremities than lower).
4. Guillain-Barré Syndrome: Ascending paralysis, usually symmetric and polyneuropathic.

5. Key Diagnostic Tests

Imaging Modalities

• MRI (Gold Standard): Provides high-resolution visualization of the spinal cord parenchyma, identifying cord compression, signal changes (edema/contusion), or mass lesions.
• CT Scan: Essential in acute trauma to evaluate bony integrity, fractures, or dislocations.
• CT Angiography/MRA: Necessary if a vascular etiology (like an AVM or spinal artery dissection) is suspected.

Electrophysiological Testing

• Somatosensory Evoked Potentials (SSEP): Useful in assessing the integrity of the dorsal columns.
• Motor Evoked Potentials (MEP): Evaluates the integrity of the corticospinal tracts.

6. Risks, Side Effects, & Management

Management of BSS is dictated by the underlying cause.

• Surgical Intervention: Indicated for penetrating trauma, compressive tumors, or unstable fractures. Decompression is prioritized to prevent secondary injury.
• Pharmacotherapy:
  • Corticosteroids: Controversial in acute SCI; generally reserved for specific inflammatory conditions.
  • Anticoagulation: If the etiology is vascular/ischemic.
• Rehabilitation: Physical and Occupational Therapy are the cornerstones of long-term recovery.

Potential Risks & Complications

• Pressure Ulcers: Due to immobility and sensory loss.
• Deep Vein Thrombosis (DVT): High risk in the acute/subacute stages of paralysis.
• Neuropathic Pain: Chronic pain often develops in the distribution of the lesion.
• Autonomic Dysreflexia: A medical emergency in lesions above T6.

7. Prognosis

Brown-Séquard Syndrome has the best prognosis of the incomplete spinal cord injury syndromes. Because the dorsal columns (responsible for proprioception) are often spared or only partially affected, patients have a high likelihood of regaining the ability to ambulate, even if some distal muscle weakness persists. Recovery typically follows a pattern of proximal to distal improvement.

8. Frequently Asked Questions (FAQ)

1. Is Brown-Séquard Syndrome permanent?

Not necessarily. Because it is an incomplete injury, many patients experience significant functional recovery, especially if the underlying cause (e.g., hematoma or tumor) is addressed promptly.

2. Can BSS occur without trauma?

Yes. Non-traumatic causes such as Multiple Sclerosis, spinal cord tumors, or vascular infarctions are well-documented.

3. What is the most common cause of BSS?

Historically, penetrating trauma (e.g., knife wounds) was the primary cause. In modern clinical settings, blunt trauma and spinal cord tumors are increasingly common etiologies.

4. Why is the pain/temperature loss on the opposite side?

Because the spinothalamic tracts decussate (cross over) within 1–2 spinal segments of entering the spinal cord. A lesion at that level interrupts the fibers that have already crossed.

5. Does BSS affect bladder function?

Generally, no. Since bladder control is mediated by bilateral pathways, unilateral lesions rarely cause permanent bladder dysfunction. If present, it is often transient.

6. What is the role of surgery in BSS?

Surgery is indicated if there is spinal instability, a foreign body (e.g., bullet fragment), or a compressive mass (e.g., epidural hematoma) that can be decompressed to facilitate recovery.

7. How long does the "spinal shock" phase last?

Spinal shock, characterized by flaccid paralysis and absent reflexes, typically lasts from a few days to several weeks.

8. Is Horner’s Syndrome always present in BSS?

No. Horner’s syndrome (ptosis, miosis, anhidrosis) only occurs if the lesion involves the sympathetic pathway in the cervical spinal cord (above T1).

9. What is the recovery trajectory for BSS?

Most patients show significant improvement in motor function within the first 6 months, with continued, albeit slower, recovery occurring up to 2 years post-injury.

10. Can I get BSS from a chiropractic adjustment?

While extremely rare, vertebral artery dissection or high-velocity cervical manipulation can, in theory, cause spinal cord vascular compromise leading to a BSS-like presentation.

9. Conclusion

Brown-Séquard Syndrome remains a classic "board-exam" diagnosis that serves as a cornerstone of clinical neurology and neurosurgery. Mastery of its pathophysiology allows clinicians to localize spinal cord lesions with exceptional precision. While the diagnosis is rare, the management of these patients requires a multidisciplinary approach involving orthopedics, neurology, physical medicine, and rehabilitation. Early identification, prompt imaging, and aggressive rehabilitation remain the primary determinants of a positive patient outcome.

Disclaimer: This document is for educational purposes only and does not constitute medical advice. Always consult with a board-certified neurologist or neurosurgeon for patient management.